MYC and cancer: At endpoint, alteration of Trp53 caused additional changes to many vital cancer pathways, notably: E2F Targets, G2M Checkpoint, Angiogenesis, MYC targets v1, Mitotic Spindle, Glycolysis and Down regulationion of UV Response.